NeuroOne Medical Technologies (NMTC) - Net earnings per share (EPS TTM)
Rising sales of Evo electrodes and the launch of OneCore systems are driving the growth of NeuroOne Medical Technologies (NMTC), as illustrated by the rolling annual earnings per share. Meanwhile, -0.92 represents the current value of this metric. Operations within the US legal framework, shielded from the impact of trade wars, ensure stability. The defensive nature of neurosurgery renders demand crisis-proof, guaranteeing revenue predictability.
NMTC (NeuroOne): analytical breakdowns and indicator data
- share price and expert price forecast:
- market capitalization indicators:
- business book valuation details:
- debt and liquidity details:
Debt to Equity NeuroOne Medical Technologies|NMTC - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital NeuroOne Corp|NMTC - Company Cumulative Debt|Debts to Book Capitalization NeuroOne Medical Technologies Corporation|NMTC - Company Long-Term Indebtedness|Company Short-Term Debts NeuroOne Medical Technologies|Quick Ratio n1mtc.com
- net income and valuation multiples indicators:
NMTC - Net Income|Projected Future Earnings NeuroOne Medical Technologies|NMTC - P/E Multiple|Future Price to Earnings NeuroOne Medical Technologies Corporation|NMTC - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio NeuroOne Medical Technologies Corporation|NMTC - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) NeuroOne Medical Technologies|NMTC - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months n1mtc.com|NMTC - Net earnings per share change in current year|Expected earnings per share growth for next year NeuroOne Medical Technologies
- sales volume and revenue information:
Basic company analysis:NeuroOne Medical Technologies (NMTC)
This indicator reflects the portion of net income attributable to a single common share over a rolling year. For NeuroOne Medical Technologies (NMTC), this calculation verifies the monetization efficiency of its diversified neurotechnology platforms. By analyzing the per-share profit trend over the last 12 months, an investor assesses the real balance of supply and demand. Product diversification within neurology minimizes the risk of overpaying for the asset. Positive momentum confirms the fundamental stability of the business.
Direct competitors
BSX: Net earnings per share for the last 12 months|Earnings per one share for the last 12 months EW|RMD: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Insulet Corp (PODD)|ZBH (Zimmer Biomet Holdings) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months COO (CooperSurgical)|Net earnings per share for the last 12 months ALGN (Align Technology, Inc.)|GMED (globusmedical.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months TransMedics Group Inc TMDX|ATEC - Net earnings per share for the last 12 months|Artivion Inc - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Enovis Inc.|IART: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months ESTA|BBNX (Beta Bionics) - Net earnings per share (EPS TTM)|IRADIMED Corp (IRMD) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) EMBC|Net earnings per share for the last 12 months Tandem Corp TNDM|Net earnings per share (EPS TTM) AXGN (AxoGen, Inc.)|Net earnings per share (EPS TTM) si-bone.com SIBN|OFIX - Earnings per share for the last twelve months|BVS: Earnings per share for the last twelve months|KIDS (orthopediatrics.com) - Net earnings per share for the last 12 months|Treace Corp - Earnings per share for the trailing year|SRTA (Strata Critical Medical Inc) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months carlsmed.com CARL|Earnings per share for the last twelve months RxSight (RXST)|clearpointneuro.com (CLPT) - Net earnings per share for the trailing year|Stereotaxis Corp - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Neuronetics, Inc STIM|Sight Sciences, Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Orchestra BioMed Inc. OBIO|anikatherapeutics.com (ANIK) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months NSPR (InspireMD Inc)|Earnings per share for the last twelve months Jin Medical International Ltd.|Net earnings per share for the last 12 months Vivani (VANI)|Net earnings per share (EPS TTM) XTNT|MODD - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Myomo MYO|COCH: Earnings per share for the last 12 months|VVOS: Net earnings per share for the last 12 months|enVVeno Corp - Earnings per share for the last four quarters|sintx.com (SINT) - Earnings per share for the last twelve months|Earnings per share for the last 12 months TNON|LFWD (Lifeward) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Autonomix AMIX|Net earnings per share for the last 12 months IVF (INVO Bioscience, Inc.)|Net earnings per share (EPS TTM) Bone Biologics Inc (BBLG)|Earnings per share for the last twelve months Axonics, Inc. AXNX|Earnings per share for the trailing year BIOL|DYNT - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Paragon 28, Inc.|invobioscience.com (INVO) - Earnings per share for the last twelve months
